]>
IRCT20180103038196N4 IRCT 2018-07-29 Gorgan University of Medical Sciences Evaluation of omega-3 supplementation intake on the risk of preeclampsia Evaluation of omega-3 supplementation intake on the risk of preeclampsia in nulliparous pregnant women 2018-05-21 anticipated 122 Complete https://irct.ir/trial/32460 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: Using SAS statistical software and block randomization. patients will be divided into two groups: Group 1: Omega-3 and Group 2: Placebo, Blinding description: The study is a double-blind, so that the patient and the person distributing the medications and the person who measures the patient's pressure are not aware of the type of treatment and drug. The medications are placed inside the two envelopes A and B, which are same shape and will Give to the person distributing the medications. 3 Pre-eclampsia. Intervention 1: Intervention group: The first group uses a gram of an EPA with DHA as an omega-3 pearl until the end of pregnancy. Intervention 2: Control group: The control group received the placebo, which is in the form of pearl containing gelatin. Yes - There is a plan to make this available What will be shared: Data are obtainable after individuals were unidentified When: Start the access after 6 months after establishing the results To whom: Professors and medical students Conditions: It does not matter Where to obtain: Send email to salimia92@gmail.com How to obtain: Using email Comments: no
public Dr Sara Shafiee
Sayyad Shirazi Hospital - Sayyad Shirazi Blv, Gorgan
Gorgan Iran (Islamic Republic of) 1234356780 +98 17 3225 1502 salimia92@yahoo.com Gorgan University of Medical Sciences scientific Dr Sara Shafiee
Sayyad Shirazi Hospital, Sayyad Shirazi Blv, Gorgan
Gorgan Iran (Islamic Republic of) 1234567890 +98 32 51291 salimia92@yahoo.com Gorgan University of Medical Sciences Iran (Islamic Republic of) nulliparous Pregnant women with 14 to 18 weeks gestational age Satisfaction to participate in the study Women without a high risk of preeclampsia (age under 20 and over 40 years, history of preeclampsia in a previous pregnancy or in the family, twins pregnancy, body mass index equal or greater than 29, kidney disease and hypertension ) Do not use calcium, aspirin, anticoagulants and insulin No history of allergy to omega-3 20 to 40 years old 20 years 40 years Female Unwillingness to cooperate Forced to use aspirin, calcium and heparin during the study Not being able to continue taking medication due to digestive problems or because of an allergic reaction Women with a high risk of preeclampsia O14 Pre-eclampsia Prevention Placebo Intervention group: The first group uses a gram of an EPA with DHA as an omega-3 pearl until the end of pregnancy. Control group: The control group received the placebo, which is in the form of pearl containing gelatin Pre-eclampsia Prevalence in Nulliparous Pregnant Women. Timepoint: From the beginning of the study to the end of pregnancy. Method of measurement: Pressure gauge and criteria for diagnosis of pre-eclampsia. Gorgan University of Medical Sciences Approved 2018-05-20 Ethics committee of gorgan University of Medical Sciences Golestan university of medical science ,Beginin of Shastkola Street, 5th Kilometers of Gorgan Sari Road, Gorgan Gorgan Golestan Iran (Islamic Republic of)